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Abstract: Whole-brain networks derived from diffusion tensor imaging (DTI) data require the
identification of seed and target regions of interest (ROIs) to assess connectivity patterns. This study
investigated how initiating tracts from gray matter (GM) or white matter (WM) seed ROIs impacts
(1) structural networks constructed from DTI data from healthy elderly (control) and individuals with
Alzheimer’s disease (AD) and (2) between-group comparisons using these networks. DTI datasets
were obtained from the Alzheimer’s disease Neuroimaging Initiative database. Deterministic
tractography was used to build two whole-brain networks for each subject; one in which tracts
were initiated from WM ROIs and another in which they were initiated from GM ROIs. With respect
to the first goal, in both groups, WM-seeded networks had approximately 400 more connections
and stronger connections (as measured by number of streamlines per connection) than GM-seeded
networks, but shared 94% of the connections found in the GM-seed networks. With respect to
the second goal, between-group comparisons revealed a stronger subnetwork (as measured by
number of streamlines per connection) in controls compared to AD using both WM-seeded and
GM-seeded networks. The comparison using WM-seeded networks produced a larger (i.e., a greater
number of connections) and more significant subnetwork in controls versus AD. Global, local, and
nodal efficiency were greater in controls compared to AD, and between-group comparisons of these
measures using WM-seeded networks had larger effect sizes than those using GM-seeded networks.
These findings affirm that seed location significantly affects the ability to detect between-group
differences in structural networks.
Keywords: DTI; Alzheimer’s disease; graph theory; structural networks; MRI; diffusion
1. Introduction
Diffusion magnetic resonance imaging (MRI) enables white matter structure to be studied in vivo.
Methods such as diffusion tensor imaging (DTI) have led to the ability to quantify the amount of
diffusion anisotropy in individual voxels in the brain as a surrogate of white matter integrity [1].
Alternatively, tractography has been used to virtually dissect white matter tracts and construct
whole-brain networks [2–7]. Network analysis methodologies, such as graph theory, have been
applied to the whole-brain networks built using diffusion tractography. In these analyses, whole-brain
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networks are modeled as a graph comprised of a set of nodes, which are typically cortical or subcortical
regions, and edges, which are the connections between them.
To construct a whole-brain structural network from DTI data, a number of methodological choices
are involved from image acquisition through tractography. The effect of different parameters on
network construction is gaining attention ([8–13], see [14] for review) because there is currently no
universally-accepted standard set of parameters. As a result, most published studies use different
methods to construct networks from diffusion MRI data. One important choice in constructing a
whole-brain structural network is how to define the nodes of the network (see [14,15] for review).
The number of nodes, how they are defined (e.g., which atlas, if any, is used), and how they are
used in the construction of the network have been shown to affect network properties such as
small-worldness [8] and hub identity [9]. While some effects of node choice have been assessed
within the same subjects, the influence of the tissue in which the node is placed (e.g., gray or white
matter) has not been evaluated in the context of disease.
One such disorder in which structural network analysis may be influenced by the location of nodes
is Alzheimer’s disease (AD). AD is the most prevalent form of dementia and has been characterized as
a “disconnection syndrome” [16,17]. Neurofibrillary tangles preferentially accumulate in pyramidal
neurons in association cortices in layers 2/3 and 5, the neurons of which make long cortico-cortical
connections [18–20]. Furthermore, amyloid beta accumulates within the highly-connected hubs of
the default mode network, which are also comprised of association cortex [21]. The accumulation of
pathology in brain hubs and the progressive degeneration of the neurons whose axons form long-range
cortico-cortical connections inevitably affect the integrity and microstructure of the white matter.
This pattern of AD neuropathology supports the characterization of AD as a disconnection syndrome
and makes it suitable for study through the analysis of whole-brain structural networks built from
diffusion MRI data.
A considerable amount of research has reported significant changes associated with AD in gray
matter [22–26], as well as white matter [27–33]. Furthermore, tractography has been utilized to examine
how connectivity between specific regions of interest (ROIs) [34–36] or within whole-brain structural
networks [37–42] differs between healthy aging and individuals with AD. These studies have all shown
decreased connectivity in AD relative to controls; however, specific differences between controls and
AD in these studies vary. Importantly, the whole-brain structural network studies that have been
conducted used different network construction methods and connection weighting, making a direct
comparison of the results difficult [14]. This speaks to the need for a common methodology in network
construction, if plausible. Regardless, a better understanding of the effects of network parameters on
constructed networks and between-group comparisons that use them is needed.
The current analysis focuses on the intersection between DTI network construction and
between-group differences—focusing on how node location affects whole-brain structural networks
constructed in healthy elderly controls and individuals with AD. To this end, we constructed two
networks for each subject using a seed-to-target ROI-based strategy and deterministic tractography.
In one network, seeding was initiated in white matter ROIs (WM-seed networks), and in the second
network, seeding was initiated in gray matter ROIs (GM-seed networks). GM ROIs were utilized as
targets in both networks. Tissue elements (i.e., axons, dendrites, blood vessels, cell bodies) in GM
voxels have mixed orientations, especially at the scale of ~2–3 mm. Despite this, a large number of
GM voxels still survive the FA threshold, are included in the tractography algorithm, and can thus be
used to generate brain networks with a large number of connections that satisfy small world criteria.
GM voxels are in close proximity to both the surface of the brain, adjacent to cerebrospinal fluid (CSF),
and white matter. In CSF voxels, there are no major barriers to the diffusion of water molecules, and
in WM voxels, there are strong and oriented barriers to the diffusion of water molecules. Within a
given GM voxel, there may be partial voluming with CSF and/or WM depending on where that voxel
is located, leading the direction of its primary eigenvector to be significantly different from that of
the primary eigenvectors of the GM or WM voxels that abut it. In contrast, WM voxels primarily
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contain axons in compacted and ordered structure. Though their orientation is far from completely
uniform within a voxel at the scale of ~2–3 mm, the fractional anisotropy (FA) of WM voxels tends to
be higher than GM voxels due to the overall geometry of axon packing. Additionally, WM voxels are
more likely to have primary eigenvectors whose direction is more similar to the WM voxels that abut
it, thus making the continuation of streamline tracking more likely. Both seeds located on the gray
matter-white matter boundary [9,43–45] and GM seeds [46–49] have been used with seed-to-target
ROI-based strategies to generate structural brain networks. Yet, to our knowledge, no systematic
evaluation of the effects of seed type on network comparisons has been performed. These factors
motivated the following analyses and led us to predict that WM-seed networks would contain a greater
number of streamlines between ROIs (i.e., “stronger” connections) than GM-seed networks and that
this would change or enhance differences in network measures found between groups.
2. Materials and Methods
2.1. Subjects
The data used in this study were obtained from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database [50]. The ADNI started in 2003 and its primary goal has been to test whether the
development of mild cognitive impairment (MCI) and AD can be measured using a combination of
imaging techniques, biomarkers, and neuropsychological assessment. For current information on the
ADNI, see [51].
Ten healthy elderly individuals (5 female) and ten individuals with AD (5 female) who underwent
DTI scanning were selected from the Alzheimer’s disease Neuroimaging Initiative (ADNI) database.
The ADNI is a multisite study, and ADNI participants are diagnosed at their respective sites using
the global Clinical Dementia Rating (CDR) scale and neuropsychological test scores. Diagnoses are
confirmed by the ADNI Clinical Core and reassessed once a year. Subject ID numbers, ages, and
global CDR scale scores of the individuals whose data were used in this study are listed in Table S1.
In planning for this study it was important to balance two factors. The first was to limit the number
of subjects included in order to ensure that any significant differences found could only come from
large effects. This provides protection from finding statistically significant but meaningless differences.
The second was to use subject selection criteria that would prevent bias in subject selection that could
influence the findings. To this end, we used a pseudo-random selection method to select the subjects
for the AD and control groups, starting from the lowest site number at which DTI scans were acquired.
Sex was intentionally balanced within and between groups. Control subjects had an average age of
69.5 (±4.9) and AD subjects had an average age of 70.1 (±10.2). A two-sample, two-tailed t-test with
unequal variance showed no significant differences in the age of subjects in each group (p = 0.865,
d = 0.08). All control subjects had a global CDR of 0. Eight AD subjects had a CDR of 1 and the
remaining two AD subjects had a CDR of 2. All subjects gave informed consent at the institutions
where data were collected upon enrollment in the ADNI.
2.2. Imaging Data
T1-weighted structural scans and DTI datasets were downloaded from the ADNI database in their
original DICOM (Digital Imaging and Communications in Medicine) format. Scans used in this study
were acquired on 3T GE scanners at multiple scanning sites. DTI data contained five volumes acquired
with a b-value of 0 and 41 directions acquired with a b-value of 1000. Additional scan parameters can
be found on the LONI website [50]. All scans were converted to NIfTI (Neuroimaging Informatics
Technology Initiative) format using dcm2nii and visually inspected prior to use.
The DTI data used in this study was acquired at a resolution of 2.73 × 2.73 × 2.7 mm and
reconstructed as 1.37 × 1.37 × 2.7 mm, which is the resolution of the data in the ADNI database.
After converting to NIfTI, FLIRT v6.0 [52,53] in FSL v5.0.8 was used to reslice each DTI dataset to its
original, nearly isotropic resolution of 2.73 × 2.73 × 2.7 mm prior to further processing.
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2.3. Network Construction
A brain network can be modeled as a graph, which is a set of nodes and edges ([54,55], see [56]
for review). In this study, we represented structural brain networks as weighted, undirected graphs.
The nodes of our structural networks were either gray matter or white matter ROIs and the edges were
streamlines generated between pairs of ROIs using deterministic tractography. Edge weights were
equal to the number of streamlines generated between each pair of ROIs with large and small numbers
of streamlines representing strong and weak connections, respectively.
2.3.1. Parcellation of Gray Matter and White Matter
Cortical surfaces were generated from each subject’s T1-weighted scan in FreeSurfer v5.3.0 [57]
(Laboratory for Computational Neuroimaging, Athinoula A. Martinos Center for Biomedical Imaging,
Charlestown, MA, USA) using the standard pipeline. Once the surfaces were created, errors in each
subject’s pial and white matter surfaces were edited manually. A total of 68 cortical gray matter (GM)
ROIs were generated using the Desikan-Killiany atlas [58] (34 per hemisphere) and used as nodes in
the whole-brain network. A total of 8 subcortical ROIs (4 per hemisphere) were generated and used in
the whole-brain network as well: amygdala, hippocampus, putamen, and thalamus. Each subject’s GM
ROIs were generated in T1 space and transformed into DTI space using bbregister, a FreeSurfer tool
that uses a boundary-based cost function for image registration [59]. This tool performs within-subject,
cross-modal coregistration of images through use of the gray matter-white matter boundary generated
from a subject’s T1-weighted anatomical image. This coregistration was used to transform ROIs in T1
space into DTI space. A selection of GM ROIs were overlaid onto each subject’s DTI data and visually
inspected prior to fiber tracking to ensure accurate transformation into DTI space.
White matter (WM) ROIs were one-voxel thick and lined the white matter surface just deep to the
gray matter ROIs (Figure 1). To create these WM ROIs, whole-brain cerebral white matter volumes
generated in FreeSurfer were eroded by one voxel and this mask was subtracted from each white
matter ROI derived from the standard FreeSurfer white matter parcellation [31]. The FreeSurfer white
matter parcellation divides the entire cerebral white matter volume into 68 regions that correspond
to the 68 GM regions produced in the cortical parcellation. Subtraction of the eroded cerebral white
matter volume from each white matter ROI allowed the one-voxel strip of white matter just under the
gray matter-white matter boundary corresponding to that ROI to be isolated. One-voxel-thick WM
ROIs were chosen to minimize the seeding volume while maintaining anatomical relevance to the GM
ROIs. WM ROIs were generated in T1 space and transformed into DTI space using the same methods
used to transform GM ROIs. A selection of WM ROIs were overlaid onto each subject’s DTI data and
visually inspected prior to fiber tracking.
The same subcortical ROIs were used to generate WM-seed and GM-seed networks because they
contain a mixture of white matter and gray matter that cannot be resolved at the spatial resolution of
this MRI dataset.
2.3.2. Tractography
Two structural networks were generated for each subject using a seed-to-target ROI-based method.
In evaluating the connections between region A and region B using a seed-to-target strategy, fiber
tracking is initiated in region A n times. The number of streamlines that reach region B corresponds to
the strength of the connection between regions A and B. To evaluate the connections between region A
and regions C, D, E, etc., this process is repeated for each ROI pair. One network was generated using
GM ROIs as seed regions and the second network was generated using the WM ROIs as seed regions.
These networks will be referred to as GM-seed and WM-seed networks, respectively, throughout the
rest of the paper. In both instances, target ROIs were placed in the gray matter.
Deterministic fiber tracking was used to generate whole-brain structural networks from DTI data
using an in-house MATLAB script employing DSI Studio (24 June 2013 build) functions [60]. The DTI
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data were reconstructed and a tensor model fit to each voxel using the DTI reconstruction scheme
implemented within DSI Studio to determine the three eigenvalues and eigenvectors for each voxel [61].
The principle eigenvector of each voxel was used in fiber tracking. For each pair of seed and target
ROIs, 10,000 seeds to initiate fiber tracking were randomly placed within voxels that survived the FA
threshold in the seed ROI. Fiber tracking continued in both directions until a voxel with an FA lower
than 0.1 or an angle exceeding 45◦ between steps was encountered. Only streamlines that reached
the target ROI were counted and entered into the connectivity matrix. The following additional fiber
tracking parameters were used: 2 mm step size, smoothing of 0.5, minimum fiber length of 5 mm,
maximum fiber length of 300 mm, random subvoxel seeding, Gaussian radial interpolation, and the
RK4 tractography algorithm. Additional corrections that removed looping streamlines were also
carried out.
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Figure 1. Generating WM ROIs. (top left) one subject’s white matter mask overlaid on that subject’s
diffusion-weighted MRI data. The WM mask was eroded by one voxel and the resulting mask is shown
in blue. Then, WM ROIs generated in FreeSurfer and transformed into diffusion space (one example
shown in transparent red) were overlaid on the eroded WM mask. The eroded WM mask was
subtracted from e ch WM ROI to isolate the strip of voxels just deep to the GM/WM interface that
was used as the final WM ROI (shown in y l ow). (top right) one subject’s left superior parietal
cortex GM ROI (red) and WM ROI (blue) overla d on an pparent diffusion coefficient (ADC) map.
The corresponding region on that subject’s T1-weighted image is shown on the far right. GM and
WM ROIs were transformed from T1 space to DTI space using bbregister, which relies on the gray
matter-white matter boundary for image alignment. The bright voxels lining the GM ROI are CSF and
the dark voxels deep to the WM ROI are white matter. On the left, the primary diffusion direction of
each voxel is visible and the map is thresholded at FA = 0.1. In this section, a greater number of WM
voxels survive the FA threshold compared to the voxels in the GM ROI (voxels that survive the FA
threshold have a diffusion tensor in them). CSF: cerebrospinal fluid, DTI: diffusion tensor imaging, FA:
fractional anisotropy, GM: gray matter, MRI: magnetic resonance imaging, ROIs: regions of interest,
WM: white matter.
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Prior to analysis, networks were symmetrized because DTI data does not contain directional
information. Any asymmetry in connection strength (i.e., number of streamlines) present after fiber
tracking for a given seed-target ROI pair is the result of ROI volume, differences between the shape
and location of seed and target regions, differences in seed placement, and accumulated error as
streamlines are generated over long distances. To symmetrize the matrices, the higher number of
streamlines between each pair of ROIs was used as the weight of each connection. This sequence of
processing steps resulted in whole-brain networks in which each connection was weighted by the
number of streamlines generated between ROIs.
2.4. Graph-Theory Network Measures
Whole-Network Measures
In the past several years, graph theory has been applied to the study of human brain networks
(see [56] for review). Small-worldness [62] is one of the most common topological measures examined
within human brain networks. Both binary and weighted structural and functional human brain
networks have been characterized as having small-world properties [63]. Thus, small-worldness of
WM-seed and GM-seed networks was examined in both controls and AD to ensure that networks
generated using both types of seed ROIs satisfied small-world criteria.
Because weighted networks were used in this study, small-worldness was evaluated using global
and local efficiency rather than path length or clustering coefficient [64,65]. Note, that global and local
efficiency are similar to path length and clustering coefficient, respectively, which are validated to
define small-worldness in binary networks [62,64,65]. Global efficiency was defined as:
Eglob =
1
n∑i∈N
∑j∈N,j 6=i (dwij )
−1
n− 1 , (1)
where n is the number of nodes and dwij is the shortest weighted path length between nodes i and j.
The local efficiency was defined as:
Eloc =
1
n∑i∈N
∑j,h∈N,j 6=i(wijwih[dwjh
(
Ni)]−1
)1/3
ki(ki − 1) , (2)
where n is the number of nodes, wij and wih are the weights of the connections between nodes i and j
and nodes i and h, respectively, ki is the degree of node i, and dwjh(Ni) is the shortest weighted path
length between nodes j and h that only contains neighbors of i. Efficiency measures were computed
using Brain Connectivity Toolbox (BCT, Version 2015-25-01) functions [66].
For all WM-seed and GM-seed networks, global efficiency and local efficiency were calculated.
A small-world network was defined as having global efficiency slightly lower than that of a random
network and local efficiency higher than that of a random network [64,65]. For each subject, the
average global and local efficiencies of 100 random weighted networks were calculated to evaluate
small-worldness. Each random network was generated through 100 rewirings of that subject’s network
at each node and preserved the number of nodes and edges, the degree distribution, and the strength
distribution of the original network. The average correlation between the strength distributions of
each subject’s original network and each of the 100 random networks was higher than 0.9.
Density and average strength of all networks were calculated. Density was defined as:
D =
e
N(N − 1) , (3)
where e is the number of edges in the network and N is the total number of nodes. Density is the ratio
of edges in a network to the total number of possible edges. Average network strength was determined
Brain Sci. 2017, 7, 37 7 of 22
by first calculating the strength (i.e., weighted degree) of each node in the network and then averaging
the strength of all nodes in the network.
2.5. Statistics
Paired t-tests were used to determine whether significant within-group differences were present
between WM-seed and GM-seed networks for both controls and AD subject groups. Two-sample
t-tests were utilized to assess differences between controls and AD in either WM-seed networks or
GM-seed networks. Equality of variance was tested using F-tests prior to performing two-sample
t-tests, and all effect sizes are presented as Cohen’s d values. Statistics were performed in MATLAB
vR2012b (MathWorks, Natick, MA, USA) and JMP Pro v12.1.0 (SAS, Cary, NC, USA).
2.5.1. Network Based Statistic (NBS)
The Network-Based Statistic (NBS) toolbox v1.2 [67] was used to determine whether significantly
different networks were present between WM-seed and GM-seed networks in both control and AD
groups. In addition, NBS was utilized to identify significantly different networks between controls
and AD using both WM and GM seeds. NBS controls for multiple comparisons through cluster-based
thresholding, where connected components of a network are considered a cluster [67]. This approach
is more sensitive to detecting differences compared to alternative methods of correcting for multiple
comparisons. However, one drawback to this technique is that no individual connection in a significant
network can be considered significant on its own.
Another widely acknowledged drawback to NBS is the arbitrary nature of threshold choice [67].
We chose our thresholds based on two main criteria: (1) NBS results containing one significant network
rather than several and (2) p-value of the significant network. For our within-group comparisons
of WM-seed to GM-seed networks for both controls and AD, an NBS threshold of 3.2 was used.
For our between-group comparisons of WM-seed networks and GM-seed networks in controls and
AD, an NBS threshold of 2 was used. These thresholds resulted in one significant network with a low
p-value for all our comparisons that showed significant results. All other NBS parameters were the
same for all comparisons: t-tests performed at every connection, a p-value threshold of 0.05 for every
connection, and 5000 permutations. The size of the significant component was measured based on
extent, not intensity.
2.6. Node-Based Measures
The networks identified using the NBS toolbox (see Section 2.5.1) were used to target nodes for
further investigation. Specifically, nodal efficiency (e.g., the average shortest path length between a
node and all other nodes in a network [68]) was examined for nodes with a large number of differential
connections in the WM-seed and GM-seed NBS networks demonstrating differences between controls
and AD. BCT functions were used as part of an in-house script to calculate the nodal efficiency of NBS
network-targeted nodes. Nodal efficiency, for node i, was defined as:
Enode,i =
∑j∈N,j 6=i (dwij )
−1
n− 1 , (4)
where n is the number of nodes and dwij is the shortest weighted path length between nodes i and j.
3. Results
3.1. WM-Seed and GM-Seed Network Characterization and Comparisons
The average number of edges in the WM-seed and GM-seed networks and the average percentage
of edges present in both networks are listed in Table 1. Every subject’s WM-seed network contained a
greater number of edges than his/her respective GM-seed network. The vast majority of connections
Brain Sci. 2017, 7, 37 8 of 22
in each subject’s GM-seed network were present within each subject’s WM-seed network. Thus,
seeding in WM ROIs provides additional connections that are not captured when seeding in GM ROIs.
The percentage of GM-seed connections present in WM-seed networks was not significantly different
between AD and controls (p = 0.77, d = 0.16).
Table 1. Number of Connections for WM-Seed and GM-Seed Networks and the Percentage of GM-Seed
Connections in WM-Seed Networks.
WM-Seed Total
Connections
GM-Seed Total
Connections
WM-Seed
Connections Not
in GM-Seed
GM-Seed
Connections Not
in WM-Seed
Percent of GM-Seed
Connections in
WM-Seed Networks
Control 1110 (80) 776 (49) 380 (59) 46 (21) 94.1% (2.5%)
AD 1089 (74) 723 (64) 411 (51) 45 (17) 93.7% (2.5%)
Values listed correspond to mean (standard deviation). AD: Alzheimer’s disease, GM: gray matter, WM:
white matter.
Network density of WM-seed networks was significantly greater than GM-seed networks in
AD (p = 4.99 × 10−9) and controls (p = 7.89 × 10−8) (see Table 2). Network density did not differ
significantly between AD and control groups for either WM-seed (p = 0.54, d = 0.29) or GM-seed
networks (p = 0.051, d = 0.91).
Table 2. Average Network Density and Strength.
WM-Seed
Network Density
GM-Seed
Network Density
WM-Seed Average
Network Strength
GM-Seed Average
Network Strength
Control 0.195 (0.0141) * 0.136 (0.00858) 1361.5 (307.9) * 572.4 (117.6)
AD 0.191 (0.0131) * 0.127 (0.0112) 1251.6 (197.3) * 579.9 (99.2)
Values listed correspond to mean (standard deviation). * p < 10−6 within-group comparisons between WM-seed
and GM-seed networks. AD: Alzheimer’s disease, GM: gray matter, WM: white matter.
The average strength of WM-seed networks was significantly higher than the average strength of
GM-seed networks in both AD (p = 1.63 × 10−8) and controls (p = 5.44 × 10−7) (see Table 2). Network
strength did not differ significantly between AD and control groups for either WM-seeds (p = 0.18,
d = 0.44) or GM-seeds (p = 0.44, d = 0.069).
3.2. Within-Group Differences in WM-Seed versus GM-Seed Networks
As a next step, matrices created from WM or GM seeds were compared for each subject using NBS
to determine if systematic differences in network topology existed based on seed location. This was
done separately for control and AD groups. NBS revealed significantly stronger networks using
WM-seeds compared to GM-seeds in both controls and AD. In controls, this network was composed
of 59 nodes and 95 edges (Figure 2) (p < 0.001). In AD, this network was comprised of 41 nodes and
57 edges (Figure 2) (p < 0.001). Thirty-eight edges were shared between the significant control and
AD subnetworks. The nodes identified with 6 or more differential connections in controls and AD are
listed in Table 3 and full network details can be found in Table S2. No significantly stronger networks
were found when GM-seed networks were compared to WM-seed networks in either controls or AD.
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Table 3. Nodes with 6 or More Differential Connections in WM-Seed > GM-Seed NBS Results in
Controls and AD.
Node Number of Differential Connections
Controls
Left precentral 6
Left superior parietal 7
Left insula 8
Right inferior parietal 6
Right lateral occipital 6
Right superior parietal 7
Right insula 11
AD
Left superior parietal 7
Right superior parietal 7
Right insula 6
AD: Alzheimer’s disease, GM: gray matter, NBS: Network Based Statistic, WM: white matter.Brain Sci. 2017, 7, 37  9 of 21 
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Figure 2. Within-Group Comparisons of WM-Seed and GM-Seed Networks using NBS. (left) Control
WM > GM. (right) AD WM > GM. Large, dark blue nodes have 6 or more differential connections.
Medium light blue nodes have between 1 and 5 differential connections. Small light blue nodes were
not part of the significant network. AD: Alzheimer’s disease, GM: gray matter, NBS: Network Based
Statistic, WM: white matter.
To further explore the difference between seeding in WM ROIs versus GM ROIs, we examined
whether this difference could be explained by FA-thresholded ROI volume. FA-thresholded ROI
volume is related to connection strength in the tractography method we used to generate networks
in this study because 10,000 seeds were placed in each ROI after FA thresholding, regardless of the
number of voxels in each ROI. To illustrate this c ncept, assume that the streamlines from two voxels
in ROI X are responsible for generating the majority of the streamli es between ROI X and ROI Y. If the
same number of se ds is randomly placed in ROI X wh n it contains 10 voxels versus 20 voxels, there
is a higher probability of a greater number of streamlines forming between ROI X and ROI Y when
ROI X contains 10 voxels compared to 20 voxels. Because a majority of WM ROIs had fewer voxels
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after FA-thresholding than their respective GM ROIs, we examined whether this could account for the
higher average connection strength in WM-seed networks.
To investigate the relationship between seed ROI volume and number of streamlines generated,
data from two control subjects were chosen at random. This analysis was performed in DSI Studio with
the same tracking parameters that were used to generate the whole-brain networks. In order to capture
a mixture of connection types, streamlines were generated and counted between the left inferior parietal
lobe and the left superior parietal lobe (intra-hemispheric, U-shaped streamlines), the left entorhinal
cortex and the left parahippocampal cortex (intra-hemispheric, non-U-shaped streamlines), and the
right rostral anterior cingulate and the left frontal pole (inter-hemispheric streamlines). The shape of
these connections were determined through visual inspection in DSI Studio. Although DTI datasets do
not carry directional information, these tracts were generated in only one direction to examine whether
seed ROI volume after FA thresholding is related to the number of streamlines generated between two
ROIs. The results from this exploration are shown in Table 4.
Table 4. Relationship between FA-Thresholded Seed ROI Volume and Number of Streamlines Generated
between ROIs.
Seed ROI FA-Thresholded Seed ROIVolume (Voxel Number)
Number of Streamlines Generated
between Seed ROI and GM Target ROI
Subject 1
WM left inferior parietal lobe 304 904
GM left inferior parietal lobe 269 264
WM left entorhinal cortex 20 1248
GM left entorhinal cortex 48 45
WM right rostral anterior cingulate 55 112
GM right rostral anterior cingulate 68 9
Subject 2
WM left inferior parietal lobe 275 99
GM left inferior parietal lobe 276 66
WM left entorhinal cortex 22 232
GM left entorhinal cortex 32 456
WM right rostral anterior cingulate 63 61
GM right rostral anterior cingulate 82 6
FA: fractional anisotropy, GM: gray matter, ROI: region of interest, WM: white matter.
In subject 1, the difference in the number of streamlines generated between each pair of ROIs
when seeding in WM ROIs compared to GM ROIs is much larger than the difference in the number
of voxels between WM ROIs and GM ROIs after FA thresholding. Furthermore, a greater number
of streamlines were generated between the left inferior parietal lobe and left superior parietal lobe
when seeding in the left inferior parietal WM ROI, which contained a greater number of voxels after
FA thresholding than the left inferior parietal GM ROI (see Table 4). Figure 3 shows a comparison
of the tracts generated between the left inferior parietal lobe and left superior parietal lobe using
GM and WM ROIs in subject 1. Qualitatively, the streamlines that form the tract between each of
these ROI pairs traverse highly similar paths regardless of whether seeding was performed in the
left inferior parietal WM or GM ROI. In subject 2, with the exception of the entorhinal cortex, fewer
voxels in each WM ROI is associated with a greater number of streamlines generated between that WM
ROI and the chosen target ROI. Similar to subject 1, the magnitude of the volume difference between
WM and GM seed ROIs is smaller than the magnitude in the difference in the number of streamlines
generated between the seed and target region. This suggests that seed ROI volume (determined in part
by FA-thresholding) has an effect on the number of streamlines generated but that other factors are
involved. The data from these two subjects demonstrate that there is a complex relationship between
ROI shape, ROI location, individual anatomy, and the number of streamlines generated between
two ROIs.
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3.3. WM-Seed and GM-Seed Weighted Whole-Network Measures
Because the WM-seed and GM-seed networks showed significantly different densities and average
strengths in within-group comparisons, we further examined whether global network measures in
weighted networks differed between WM-seed and GM-seed networks within each group. Small-world
properties of these networks were also determined. Table 5 shows the average global efficiency and
average local efficiency for WM-seed and GM-seed networks and the equivalent random networks in
both groups.
Table 5. Weighted Global Network Measures.
Network Weighted GlobalEfficiency
Weighted Global
Efficiency (Random)
Weighted Local
Efficiency
Weighted Local
Efficiency (Random)
Control WM-seed 72.8 (20.3) 84.7 (20.3) 52.8 (11.3) 30.6 (7.78)
Control GM-seed 29.2 (7.47) 36.5 (7.89) 26.2 (4.52) 11.5 (3.01)
AD WM-seed 62.6 (10.4) 77.5 (12.6) 46.8 (8.71) 27.3 (4.71)
AD GM-seed 27.9 (5.23) 36.5 (6.54) 26.8 (5.38) 10.5 (2.36)
Values listed correspond to mean (standard deviation). AD: Alzheimer’s disease, GM: gray matter, WM:
white matter.
Global efficiency was significantly greater in WM-seed than GM-seed networks in both controls
and individuals with AD (p = 3.26 × 10−6, p = 1.4 × 10−7). Local efficiency was also greater in
WM-seed compared to GM-seed networks in both controls and individuals with AD (p = 2.23 × 10−6,
p = 8.19 × 10−6).
A small-world network is defined as having a global efficiency slightly smaller than that of a
random network and a local efficiency greater than that of a random network [64,65]. As Table 5
shows, this is true, on average, for both WM-seed and GM-seed networks in both controls and AD.
More importantly, the global and local efficiency measures of each subject’s WM-seed and GM-seed
networks satisfied these small-world criteria, confirming that each network generated for every subject
can be considered a small-world network at the individual level (see Table S3).
Between-group differences in whole-network efficiency measures using WM-seed or GM-seed
networks were also examined. Both the global and the local efficiency were decreased in AD compared
to controls using WM-seed networks (Eglob: p = 0.0881, d = 0.664, Eloc: p = 0.101, d = 0.6) and GM-seed
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networks (Eglob: p = 0.317, d = 0.205, Eloc: p = 0.604, d = 0.12). These comparisons did not reach
significance, but the effect size was larger for the comparisons performed using WM-seed networks.
3.4. Between-Group Differences Using WM-Seed and GM-Seed Networks
The effect of seed location on network changes in AD compared to normal aging was determined.
A network showing significant decreases in AD compared to controls was observed when comparisons
were performed between both the WM-seed (p = 0.004) and GM-seed (p = 0.0326) networks.
The network generated from the WM-seed network comparison contained 25 nodes and 27 edges
(see Figure 4 and Table S4). The network generated from the GM-seed network comparison contained
10 nodes and 9 connections (see Figure 4 and Table S4). Five out of the nine connections in this network
were present in the larger network generated by the WM-seed network comparison. This suggests that
some unique features may be captured by the GM-seed networks despite the fact that a much larger
and more significant network was found when the WM-seed networks were compared. No significant
networks were found that were greater in AD relative to controls using either seeding method.
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Figure 4. Between-Group Comparisons using WM-Seed and GM-Seed Networks. (left) Control > AD,
WM ROIs. Nodes with a high number of differential connections are the left entorhinal
cortex, left isthmus cingulate, left thalamus, right precuneus, and right superior parietal lobule.
(right) Control > AD, GM ROIs. The left thalamus was the only node with a high number of differential
connections. Large dark blue nodes have 4 or more differential connections, medium light blue nodes
have 1–3 differential connections. Small light blue nod s were not part of the significant network. AD:
Alzheimer’s disease, GM: gray matter, ROIs: regions of i t, : white matter.
3.5. Targeted Node-Based Differences between Controls and AD
Lastly, the effect of seed location (e.g., GM or WM) on differences in nodal efficiency between AD
and control groups was investigated. The targeted nodes were determined from the results presented
in Section 3.4. Nodal efficiency was calculated for nodes with 4 or more and 2 or more differential
connections in the WM-seed and GM-seed NBS network , respectively, that showed decr ases in AD
compar d to con rols. Th criteria for selecting nodes for this analysis differ d for t e NBS etworks
generated using WM-seed and GM-seed networks to ensure that the nodal efficiency of an equal
number of nodes were tested from each network. The nodes included in this analysis are shown in
Table 6.
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Table 6. Nodes Used in Nodal Efficiency Comparisons.
WM-Seed Network Node Degree in Significant NBS Network
Left entorhinal cortex 4
Left isthmus cingulate 5
Left thalamus 5
Right precuneus 4
Right superior parietal cortex 5
GM-Seed Network Node Degree in Significant NBS Network
Left precentral gyrus 2
Left rostral middle frontal gyrus 2
Left temporal pole 2
Left hippocampus 2
Left thalamus 5
GM: gray matter, NBS: Network Based Statistic, WM: white matter.
When using WM-seed networks, the nodal efficiency of the left entorhinal cortex (p = 0.0066), left
thalamus (p = 0.041), left precentral gyrus (p = 0.0224), left rostral middle frontal cortex (p = 0.0065),
and left hippocampus (p = 0.0121) were all significantly reduced in AD compared to controls (Table 7).
The left entorhinal cortex (padj = 0.0297), left rostral middle frontal cortex (padj = 0.0297), and left
hippocampus (padj = 0.0363) survived false discovery rate (FDR) correction for multiple comparisons.
The left precentral gyrus nearly survived FDR correction with a padj equal to 0.0504.
Table 7. Average Nodal Efficiency WM-Seed and GM-Seed Networks.
Node Control WM-SeedNodal Efficiency
AD WM-Seed
Nodal Efficiency
Control GM-Seed
Nodal Efficiency
AD GM-Seed
Nodal Efficiency
Left entorhinal 108 (44.3) ** 63.2 (27.5) 51.2 (26.5) 35.2 (14.8)
Left isthmus cingulate 81.6 (32.5) * 62.3 (16.1) 28.8 (10.5) 29.5 (9.44)
Left thalamus 89.9 (33.4) * 66.1 (23.1) 52.2 (20.3) ** 31.1 (11.1)
Right precuneus 97.1 (41) 74.1 (29.6) 28.4 (11.5) 25.9 (9.15)
Right superior parietal cortex 103 (35.7) 88.6 (30.4) 32.2 (10.4) 31.8 (8.8)
Left precentral gyrus 106 (30.4) * 80.9 (20.3) 49.4 (17.5) 37.1 (11)
Left rostral middle frontal gyrus 66.7 (14.4) ** 51.7 (9.46) 28.2 (5.44) 25.6 (7.48)
Left temporal pole 95.6 (35) * 73.6 (25.1) 52.9 (16.3) 44.1 (14.2)
Left hippocampus 95 (25.5) ** 67.1 (25.2) 40.2 (14.4) 31.3 (13.4)
Values listed correspond to mean (standard deviation). * FDR adjusted p value < 0.08 for Control > AD, WM-seed or
GM-seed comparisons ** FDR adjusted p value < 0.05 for Control > AD, WM-seed or GM-seed comparisons. AD:
Alzheimer’s disease, FDR: false discovery rate, GM: gray matter, WM: white matter.
When using GM-seed networks, the nodal efficiency of the left thalamus (p = 0.005) and left
precentral gyrus (p = 0.0383), were significantly reduced in AD compared to controls. Only the
left thalamus survived FDR correction with a padj equal to 0.045. Similar to the power calculations
presented for the global and local efficiency comparisons, the Cohen’s d values for the WM-seed
network comparisons were stronger for all nodes except for the left thalamus (see Table S5).
4. Discussion
4.1. The Effects of Seed Location on Properties of WM-Seed and GM-Seed Networks
The results presented in Section 3.1 show that the WM-seed networks have a greater number of
connections than the GM-seed networks in both AD and controls. Furthermore, most of the connections
present in the GM-seed networks are also present in the WM-seed networks in both groups. Network
density and network strength are higher in WM-seed than in GM-seed networks in both AD and
controls. Network density is directly related to the number of connections present within a network
and network strength is indirectly related to the number of connections within a network. Thus,
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it makes sense that both density and strength were higher in the WM-seed networks, which contained
more connections.
The NBS results presented in Section 3.2 and Figure 2 complement the data in Section 3.1 and
show that there is a significantly stronger subnetwork of regions (with some overlap) in WM-seed
networks compared to GM-seed networks in controls and AD. Interestingly, the superior parietal
cortex and insula were among the nodes with the highest number of differential connections in both
the control and AD WM-seed networks. This suggests that for some regions, seeding in GM ROIs is
unable to capture many of the connections between those regions and the rest of the brain. This could
be due to a greater amount of partial voluming with CSF in these GM ROIs, large differences in the
directions of the primary eigenvectors of the voxels in the GM ROIs compared to those of the voxels
in the WM ROIs (which would result in streamlines failing the angle threshold), or differences in
the three-dimensional geometry of these GM ROIs relative to their corresponding WM ROIs that
significantly affect the number of streamlines generated from these regions. Further exploration of
this in two control subjects (Table 4) suggested that FA-thresholded seed ROI volume does have an
effect on the number of streamlines generated, but that there is a complex relationship between ROI
shape, ROI location, individual anatomy, and the number of streamlines generated between two ROIs.
These factors should be investigated in future research to better understand biases that may be present
in between-group structural network comparisons.
Comparisons of global and local efficiency calculated from WM-seed and GM-seed networks
followed a similar trend to that found with network strength and density in both controls and
AD. Both global and local efficiency were stronger in WM-seed networks compared to GM-seed
networks in both controls and AD. These results are in accordance with the results in Section 3.1,
which show that the WM-seed networks have both a greater number of connections and, on average,
stronger connections (i.e., a greater number of streamlines generated between regions) than the
GM-seed networks.
Overall, these results show that both WM-seed and GM-seed networks satisfy small-world criteria,
but that there are systematic differences in the construction of WM-seed and GM-seed networks and
the weighting within them in both AD and controls.
4.2. Differences between AD and Controls and the Effects of Seed Location on These Differences
Our main question in this study was how seed location affects between-group structural network
comparisons. We examined this at both the network and nodal levels and found that, in most cases,
comparisons between AD and controls using WM-seed networks had stronger effect sizes than
comparisons using GM-seed networks.
Network strength and density were not significantly different between AD and controls using
WM-seed networks. However, both measures were lower in AD compared to controls, which is the
expected direction of difference. While network strength was not different between AD and controls
using GM-seed networks, network density was lower in AD compared to controls using GM-seed
networks and this approached significance (p = 0.051). This could be related to the effect of AD-related
cortical thinning on the FA of GM seeds. Cortical thinning is apparent in individuals with AD compared
to healthy aged individuals [69–71] and this was also true in our sample (ADthickness = 2.13 mm,
Controlthickness = 2.27 mm, p = 0.008). Because transformation from T1 to DTI space is based on the
gray matter-white matter boundary, a thinner cortex would lower the FA of GM seeds due to partial
voluming with CSF. In this case, network density could be artificially deflated in an AD population
as a result of thinner cortex. This illustrates one aspect of the importance of parameter choice on
between-group comparisons involving neurodegenerative disorders.
Global and local efficiency are two measures commonly used to characterize and compare
weighted networks. We compared the global and local efficiency of controls and AD using WM-seed
and GM-seed networks. The global and local efficiency were lower in AD relative to controls in all
comparisons (except for the local efficiency of GM-seed networks), but none of these differences
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were significant. Though these p values are not significant, the p values corresponding to the
WM-seed network between-group comparisons are lower than those corresponding to the GM-seed
network comparisons. The effect size is also larger for the efficiency comparisons using WM-seed
networks (Eglob: d = 0.664, Eloc: d = 0.6, medium effect size) versus GM-seed networks (Eglob: d = 0.205,
Eloc: d = 0.12, small effect size). To have an 80% chance of finding a significant difference between these
measures using DTI data and this set of network construction parameters would require approximately
33-45 subjects if WM-seed networks were used. In contrast, over 390 subjects would be needed if
GM-seed networks were used. This suggests WM-seed networks might be more sensitive to differences
between AD and controls when comparing whole-network measures. This could be due to the greater
number of streamlines between regions captured by WM-seed networks. With a greater sample size,
it is expected that the trends in our results would reach significance as lower network efficiency in
weighted structural networks in individuals with AD compared to controls has been reported in the
literature [37,42].
Seed location affected the NBS results of the comparisons between controls and AD. The network
generated from the WM-seed network comparison was larger and more significant than that generated
from the GM-seed network comparison. The WM-seed network comparison result included nodes that
are known to be affected in AD such as the entorhinal cortex [23,72,73], isthmus of the cingulate [74–76],
precuneus [21,24,77], and thalamus [78–80]. The network generated from the GM-seed network
comparison was largely localized to the left hemisphere and also included nodes known to be affected
in AD, such as the hippocampus [72,81], thalamus, and temporal pole [82,83]. This network was
smaller and less significant than that found when using the WM seeds. Despite this, four out of
the nine connections in this network were present in the larger network generated by the WM-seed
network comparison, suggesting that some unique features may be captured by the GM-seed networks.
This is also reflected in the small number of connections (~45) that were found to be unique to the
GM-seed networks in each subject (see Table 1).
Interestingly, the left thalamus showed five differential connections in both significant networks
and four out of these five connections were the same in both seeding conditions. The GM-seed network
contained a connection between the left thalamus and the left rostral middle frontal cortex, which
was not present in the WM-seed network. Conversely, the WM-seed network contained a connection
between the left thalamus and the right superior parietal cortex that was not present in the GM-seed
network. Because the thalamus is a subcortical ROI, the same ROI was used in generating both the
WM-seed and GM-seed networks. Thus, it makes sense that similar differences between controls and
AD would be present with respect to this node. However, even though the hippocampus ROI was
also the same in both WM and GM seeding conditions, it was present in the network generated when
GM-seed networks were compared but not when WM-seed networks were compared. This additionally
reflects the possibility that GM-seed networks capture some unique and important features that the
WM-seed networks do not.
Wang et al. [42] recently used DTI and high angular resolution diffusion imaging (HARDI) [84]
to assess differences in structural networks between controls and individuals with AD. They found
weaker connections associated with the right thalamus, left hippocampus, bilateral precuneus, and
right parahippocampal gyrus, among other regions. The NBS networks shown in Figure 4 similarly
include the bilateral thalamus, left hippocampus, bilateral precuneus, and left hippocampal gyrus.
Despite methodological differences (e.g., diffusion encoding scheme, fiber orientation reconstruction
method, and statistical method), connections to similar regions were found in the present study and
Wang et al. [42].
Lastly, the effect of seed location on the nodal efficiency of 9 nodes was examined. These nodes
were selected based on the NBS results of the comparisons between controls and AD. Similar to the
global and local efficiency results, the effect sizes of 9 out of 10 comparisons of nodal efficiency between
controls and AD were larger for comparisons that used the WM-seed networks. The only comparison
with an effect size larger for GM-seed networks was the thalamus. Regardless, the nodal efficiency of
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the thalamus was found to be lower in AD compared to controls using both WM-seed and GM-seed
networks, which is the expected result.
Lo et al. [37] examined differences in the nodal efficiency of structural networks built from DTI
data between controls and individuals with AD. They found significantly reduced nodal efficiency of
nodes primarily in the right frontal lobe and in the right temporal pole. We found significantly reduced
nodal efficiency in a left frontal lobe and the decreased nodal efficiency in the left temporal pole in AD
approached significance. Lo and colleagues also found significantly reduced nodal efficiency in the left
superior frontal gyrus, which in addition to other frontal regions was included in our NBS networks.
In contrast to Lo et al., our nodal efficiency assessments were targeted by our NBS results, thus limiting
the number of statistical comparisons and the nodes tested. Furthermore, our network weights were
derived from the number of streamlines between regions while Lo et al.’s networks were weighted by
both number of streamlines and FA – fundamentally changing what the connections represent [14].
Wang et al. [42] also examined differences in nodal efficiency between controls and AD and found
reduced nodal efficiency in the left temporal pole, among other regions. We found decreased nodal
efficiency in the left temporal pole in AD relative to controls that approached significance. Similar to
Lo et al., more overlap in decreased nodal efficiency may have been found if the methodologies used
between our study and Wang et al. were more similar.
A greater number of the nodes examined—including the entorhinal cortex and
hippocampus—had significantly reduced nodal efficiency in AD compared to controls when
using WM-seed networks as opposed to when using GM-seed networks. Furthermore, the observed
reductions were more significant when utilizing WM-seed compared to GM-seed networks to perform
the comparisons. These results are in agreement with the global efficiency, local efficiency, and NBS
results. Together the results indicate that WM-seed networks produce a greater number of and more
highly significant differences in between-group comparisons of controls and AD.
5. Conclusions
The data presented demonstrate that seed location (i.e., GM or WM) has an effect on both network
construction and subsequent between-group network analyses. When forming whole-brain structural
networks using a seed-to-target ROI-based strategy and deterministic tractography, seeding in WM
ROIs produces stronger networks with a greater number of connections than seeding in GM ROIs.
In the present study, freely-available and widely used GM and WM parcellations within FreeSurfer
were used to construct network nodes. However, this is not necessarily the ideal parcellation for
structural connectivity analyses or studies of aging and AD. Likely, the choice of parcellation will
reflect the goals of a particular study and parcellation schemes for use in connectivity studies are
continuing to evolve [85]. Furthermore, it has been shown that the number of nodes affects network
properties and graph theory measures more than the specific parcellation scheme (see [14] for review).
Thus, our results suggest that seeding in white matter regions adjacent to gray matter regions, though
they may be divided according to a different parcellation scheme, is nevertheless preferable.
Between-group comparisons of whole-brain networks, whole-network measures, and node-based
measures produced a greater number of and more strongly significant differences between AD and
control groups when WM-seed networks were used. WM-seed networks had a greater number of
connections than GM-seed networks in both AD and controls and the vast majority of connections
in GM-seed networks were present in WM-seed networks. A small number of connections were
present in GM-seed networks that were not present in WM-seed networks. Though the GM-seed
between-group NBS result was less significant and less extensive compared to the WM-seed NBS
result, it did include nodes such as the hippocampus and temporal pole (not present in the WM-seed
NBS result) that are affected in AD. This suggests that it may be beneficial to include the ~50 unique
connections captured in each subject’s GM-seed network in his/her WM-seed network to more fully
capture the underlying structural network. While this particular strategy has not been investigated or
suggested in the literature, the idea of producing multiple networks for each subject in order to isolate
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or capture important features has been suggested and used [12,14]. Our strategy is one example that
may be useful in structural network studies and should be systematically investigated in future work.
Overall, our results suggest that seeding in WM ROIs captures more of the underlying streamlines
between regions than seeding in GM ROIs and highlights the importance of parameter choice on
between-group structural network comparisons. It is recognized that parameter and methodology
selection in structural network studies is a hard problem with a number of solutions, some of which
may be more appropriate for a given application than others [10,12,85]. Thus, papers that have assessed
the effect of parameter choice on network properties, including this study, have tended to focus on
the effects of one parameter or methodology on network properties [8–10]. A better understanding of
the effects of parameter choice on networks constructed using different methodologies will provide
investigators with the tools necessary to make more informed decisions on parameters in order to
maximize the power of their experiments. If we are to use these highly informative network-based
methods moving forward in the study of disease, evaluation of therapeutic interventions, or as a
diagnostic tool, the methodology used to construct whole-brain structural networks must be in the
forefront. It is unreasonable to expect that the field will adopt one method as a network-construction
standard. Despite this, further study into the effects of various network-construction parameters on
between-group comparisons are warranted to better understand how parameters affect the ability of
networks and network measures to detect differences.
Supplementary Materials: The following are available online at www.mdpi.com/2076-3425/7/4/37/s1, Table S1:
ADNI Database Subject Numbers, Ages, and Global Clinical Dementia Rating (CDR) Scale Score, Table S2: Full
List of Connections in Control WM > GM and AD WM > GM Significant NBS Networks, Table S3: Eglob and Eloc
values from each subject’s WM-seed and GM-seed Networks, Table S4: Full List of Connections in Control > AD
WM-Seed and Control > AD GM-Seed Significant NBS Networks, Table S5: Uncorrected p Values and Cohen’s d
Values from Control > AD WM-Seed and GM-Seed Targeted Nodal Efficiency Comparisons.
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